Compare ADVB & DLXY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADVB | DLXY |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | Singapore |
| Employees | 31 | 11 |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1M | 8.1M |
| IPO Year | N/A | N/A |
| Metric | ADVB | DLXY |
|---|---|---|
| Price | $3.71 | $0.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 23.4K | ★ 166.2K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $1.26 | $11.23 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.19 | $0.34 |
| 52 Week High | $7.70 | $7.00 |
| Indicator | ADVB | DLXY |
|---|---|---|
| Relative Strength Index (RSI) | 39.56 | 47.13 |
| Support Level | $3.73 | $0.46 |
| Resistance Level | $5.83 | $0.95 |
| Average True Range (ATR) | 0.53 | 0.07 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 3.03 | 82.32 |
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
Delixy Holdings Ltd a holding company. Through its subsidiary, it is principally engaged in the trading of oil-related products, which are broadly categorized into crude oil and oil-based products, including naphtha, motor gasoline, gas oil, fuel oil, asphalt, base oil, and other petrochemicals. These products are traded across multiple countries in Southeast Asia, East Asia, and the Middle East, and the Group has established a presence in the oil trading markets in these countries. The majority of the Group's revenue is generated from the trading of crude oil. Geographically, it derives maximum revenue from its business in East Asia.